NEU 1.15% $20.62 neuren pharmaceuticals limited

Retas Skyclavs was one of the biggest in 2023 for $7.3bn US by...

  1. 2,165 Posts.
    lightbulb Created with Sketch. 570
    Retas Skyclavs was one of the biggest in 2023 for $7.3bn US by Biogen rare disease drug estimate 5,000 patients in US and $1.5bn sales 2030….. premium was only 60% on their share price at the time.

    2591 ‘s potential patients with only current x 4 indications is x 10 (as per presentations) that of Skyclavs with scope for many more potentially…..

    Retas deal x 10 is $10-15bn in sales 2030-2033 US only for the potential future of 2591 as a starting point. Likely $30 bn globally…

    Fairly attractive asset.


 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
(20min delay)
Last
$20.62
Change
-0.240(1.15%)
Mkt cap ! $2.635B
Open High Low Value Volume
$20.45 $20.62 $20.26 $4.698M 229.0K

Buyers (Bids)

No. Vol. Price($)
1 221 $20.60
 

Sellers (Offers)

Price($) Vol. No.
$20.62 1553 1
View Market Depth
Last trade - 16.10pm 27/06/2024 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.